These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188 [TBL] [Abstract][Full Text] [Related]
10. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350 [TBL] [Abstract][Full Text] [Related]
11. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study. Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222 [TBL] [Abstract][Full Text] [Related]
12. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355 [TBL] [Abstract][Full Text] [Related]
13. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157 [TBL] [Abstract][Full Text] [Related]
14. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. Boileau I; Nakajima S; Payer D Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509 [TBL] [Abstract][Full Text] [Related]
15. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [ Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971 [TBL] [Abstract][Full Text] [Related]
16. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147 [TBL] [Abstract][Full Text] [Related]
17. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Ray NJ; Miyasaki JM; Zurowski M; Ko JH; Cho SS; Pellecchia G; Antonelli F; Houle S; Lang AE; Strafella AP Neurobiol Dis; 2012 Dec; 48(3):519-25. PubMed ID: 22766031 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO. Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639 [TBL] [Abstract][Full Text] [Related]
19. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219 [TBL] [Abstract][Full Text] [Related]
20. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating. Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]